Xenon Pharmaceuticals Stock Price on December 3, 2024
XENE Stock | USD 34.26 0.20 0.58% |
If you're considering investing in Xenon Stock, it is important to understand the factors that can impact its price. As of today, the current price of Xenon Pharmaceuticals stands at 34.26, as last reported on the 30th of March, with the highest price reaching 34.80 and the lowest price hitting 33.83 during the day. Xenon Pharmaceuticals shows Sharpe Ratio of -0.0864, which attests that the company had a -0.0864 % return per unit of risk over the last 3 months. Xenon Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Xenon Pharmaceuticals' Market Risk Adjusted Performance of 0.7203, standard deviation of 1.97, and Mean Deviation of 1.51 to validate the risk estimate we provide.
Xenon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Xenon |
Sharpe Ratio = -0.0864
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | XENE |
Estimated Market Risk
1.97 actual daily | 17 83% of assets are more volatile |
Expected Return
-0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Xenon Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xenon Pharmaceuticals by adding Xenon Pharmaceuticals to a well-diversified portfolio.
Related Headline
Kronos Bio Headline on 3rd of December 2024
Wells Fargo to sell San Francisco headquarters, according to... by finance.yahoo.com
SAN FRANCISCO Longstanding San Francisco financial institution Wells Fargo Bank will sell its headquarters on the citys Montgomery Street, according to a report Tuesday in the Wall Street Journal. The sale of the financial district office is part of the banks broader shift of power to the East Coast, according to the WSJ.
Xenon Pharmaceuticals Valuation on December 3, 2024
It is possible to determine the worth of Xenon Pharmaceuticals on a given historical date. On December 3, 2024 Xenon was worth 42.0 at the beginning of the trading date compared to the closed value of 42.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Xenon Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Xenon Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xenon Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Xenon Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
42.59 | 43.10 | 41.84 | 42.12 | 319,800 | |
12/03/2024 | 42.00 | 42.60 | 41.57 | 42.00 | 290,900 |
42.13 | 43.00 | 41.84 | 42.34 | 281,100 |
Backtest Xenon Pharmaceuticals | | | Xenon Pharmaceuticals History | | | Xenon Pharmaceuticals Valuation | Previous | Next |
Xenon Pharmaceuticals Trading Date Momentum on December 3, 2024
On December 04 2024 Xenon Pharmaceuticals was traded for 42.34 at the closing time. The top price for the day was 43.00 and the lowest listed price was 41.84 . The trading volume for the day was 281.1 K. The trading history from December 4, 2024 was a factor to the next trading day price growth. The trading price change against the next closing price was 0.81% . The trading price change against the current closing price is 7.10% . |
Xenon Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Xenon Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Xenon Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Xenon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Xenon Pharmaceuticals Stock history
Xenon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xenon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xenon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xenon Pharmaceuticals stock prices may prove useful in developing a viable investing in Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada. Xenon Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people.
Xenon Pharmaceuticals Stock Technical Analysis
Xenon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Xenon Pharmaceuticals Period Price Range
Low | March 30, 2025
| High |
0.00 | 0.00 |
Xenon Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Xenon Pharmaceuticals March 30, 2025 Market Strength
Market strength indicators help investors to evaluate how Xenon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xenon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xenon Pharmaceuticals stock market strength indicators, traders can identify Xenon Pharmaceuticals entry and exit signals to maximize returns
Xenon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Xenon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Xenon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xenon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.19) | |||
Total Risk Alpha | (0.06) | |||
Treynor Ratio | 0.7103 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |